Authors:
Paquet, ME
Pece-Barbara, N
Vera, S
Cymerman, U
Karabegovic, A
Shovlin, C
Letarte, M
Citation: Me. Paquet et al., Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function, HUM MOL GEN, 10(13), 2001, pp. 1347-1357
Authors:
Cho, SK
Bourdeau, A
Letarte, M
Zuniga-Pflucker, JC
Citation: Sk. Cho et al., Expression and function of CD105 during the onset of hematopoiesis from Flk1(+) precursors, BLOOD, 98(13), 2001, pp. 3635-3642
Authors:
Bourdeau, A
Faughnan, ME
McDonald, ML
Paterson, AD
Wanless, IR
Letarte, M
Citation: A. Bourdeau et al., Potential role of modifier genes influencing transforming growth factor-beta 1 levels in the development of vascular defects in endoglin heterozygousmice with hereditary hemorrhagic telangiectasia, AM J PATH, 158(6), 2001, pp. 2011-2020
Authors:
Ma, XL
Labinaz, M
Goldstein, J
Miller, H
Keon, WJ
Letarte, M
O'Brien, E
Citation: Xl. Ma et al., Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration, ART THROM V, 20(12), 2000, pp. 2546-2552
Citation: A. Bourdeau et al., Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia, TREND CARD, 10(7), 2000, pp. 279-285
Authors:
Abdalla, SA
Pece-Barbara, N
Vera, S
Tapia, E
Paez, E
Bernabeu, C
Letarte, M
Citation: Sa. Abdalla et al., Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2, HUM MOL GEN, 9(8), 2000, pp. 1227-1237
Authors:
Matsubara, S
Bourdeau, A
terBrugge, KG
Wallace, C
Letarte, M
Citation: S. Matsubara et al., Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations, STROKE, 31(11), 2000, pp. 2653-2660
Authors:
Cymerman, U
Vera, S
Pece-Barbara, N
Bourdeau, A
White, RI
Dunn, J
Letarte, M
Citation: U. Cymerman et al., Identification of hereditary hemorrhagic telangiectasia type 1 in newbornsby protein expression and mutation analysis of endoglin, PEDIAT RES, 47(1), 2000, pp. 24-35
Authors:
Evangelou, A
Jindal, SK
Brown, TJ
Letarte, M
Citation: A. Evangelou et al., Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells, CANCER RES, 60(4), 2000, pp. 929-935
Authors:
Bourdeau, A
Cymerman, U
Paquet, ME
Meschino, W
McKinnon, WC
Guttmacher, AE
Becker, L
Letarte, M
Citation: A. Bourdeau et al., Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1, AM J PATH, 156(3), 2000, pp. 911-923
Authors:
Pece-Barbara, N
Cymerman, U
Vera, S
Marchuk, DA
Letarte, M
Citation: N. Pece-barbara et al., Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1, HUM MOL GEN, 8(12), 1999, pp. 2171-2181
Authors:
Guerrero-Esteo, M
Lastres, P
Letamendia, A
Perez-Alvarez, MJ
Langa, C
Lopez, LA
Fabra, A
Garcia-Pardo, A
Vera, S
Letarte, M
Bernabeu, C
Citation: M. Guerrero-esteo et al., Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts, EUR J CELL, 78(9), 1999, pp. 614-623
Citation: Cl. Shovlin et M. Letarte, Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms, THORAX, 54(8), 1999, pp. 714-729
Citation: Np. Barbara et al., Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily, J BIOL CHEM, 274(2), 1999, pp. 584-594